Optimal duration of G-CSF prophylaxis after docetaxel (D) + epirubicin (E) in metastatic breast cancer (MBC): Prediction using a mathematical model

G. Freyer, O. Trédan, C. Meille, D. Barbolosi, B. Tranchand, P. Girard, A. Iliadis

Source record

Source: Crossref

Published: Jun 1, 2005

DOI: 10.1200/jco.2005.23.16_suppl.2044

Open original source ↗

Evidence graph

No public relationships recorded yet.

Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.